Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed the day trading at $17.42 down -0.46% from the previous closing price of $17.50. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 2.01 million shares were traded.
Ratios:
For a better understanding of SBRA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 62.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.35. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.89.
On January 07, 2025, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $20.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 24 ’25 when Cusack Catherine bought 1,500 shares for $15.92 per share. The transaction valued at 23,880 led to the insider holds 60,583 shares of the business.
Cusack Catherine bought 1,000 shares of SBRA for $16,435 on Feb 21 ’25. The Director now owns 59,083 shares after completing the transaction at $16.43 per share. On May 22 ’24, another insider, Cusack Catherine, who serves as the Director of the company, bought 7,000 shares for $14.43 each. As a result, the insider paid 101,010 and bolstered with 46,385 shares of the company.
Valuation Measures:
As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.52, and their Forward P/E ratio for the next fiscal year is 22.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.91 while its Price-to-Book (P/B) ratio in mrq is 1.51.
Stock Price History:
Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $13.46. The 50-Day Moving Average of the stock is 1.85%, while the 200-Day Moving Average is calculated to be 0.19%.
Shares Statistics:
A total of 237.59M shares are outstanding, with a floating share count of 233.61M. Insiders hold about 1.81% of the company’s shares, while institutions hold 98.57% stake in the company.
